Use of High-cost Systemic Treatments in Elderly mCRC Patients
- PMID: 27547951
- PMCID: PMC5145731
- DOI: 10.1097/MLR.0000000000000612
Use of High-cost Systemic Treatments in Elderly mCRC Patients
Comment on
-
Trends in the Treatment of Metastatic Colon and Rectal Cancer in Elderly Patients.Med Care. 2016 May;54(5):490-7. doi: 10.1097/MLR.0000000000000510. Med Care. 2016. PMID: 26900834
-
Trends in the Treatment of Metastatic Colon and Rectal Cancer in Elderly Patients.Med Care. 2017 Jan;55(1):86. doi: 10.1097/MLR.0000000000000611. Med Care. 2017. PMID: 27479601 No abstract available.
References
-
- Kumar R, Jain K, Beeke C, et al. A population-based study of metastatic colorectal cancer in individuals aged >/= 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal Cancer. Cancer. 2013;119(4):722–728. - PubMed
-
- Keenan PS, Elliott MN, Cleary PD, Zaslavsky AM, Landon BE. Quality assessments by sick and healthy beneficiaries in traditional Medicare and Medicare managed care. Med Care. 2009;47(8):882–888. - PubMed
-
- Landon BE, Zaslavsky AM, Bernard SL, Cioffi MJ, Cleary PD. Comparison of performance of traditional Medicare vs Medicare managed care. JAMA. 2004;291(14):1744–1752. - PubMed
-
- Whalen J. Why the U.S. pays more than other countries for drugs. [Accessed May 11, 2016];Wall Street Journal. 2015 http://www.wsj.com/articles/why-the-u-s-pays-more-than-other-countries-f....
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical